Life Sciences

Noninvasive Cancer Diagnostics and Technologies Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in ...

Report Code : A00008 | Category : Life Sciences

Oncology-Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A00042 | Pages : 250 | Category : Life Sciences

Lung Cancer Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. ...

Report Code : A00260 | Category : Life Sciences

Global Ovarian Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global ovarian cancer drugs market was valued at $2.3 billion in 2021, and is projected to reach $5.1 billion by 2031, growing at a CAGR of 8.4% from 2022 to 2031.

Report Code : A00273 | Pages : 189 | Category : Life Sciences

Cervical Cancer Diagnostic Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global cervical cancer diagnostic market was valued at $7.8 billion in 2022, and is projected to reach $12.7 billion by 2032, growing at a CAGR of 5% from 2023 to 2032.

Report Code : A00304 | Pages : 228 | Category : Life Sciences

Cancer Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.

Report Code : A00381 | Pages : 261 | Category : Life Sciences

Cancer Genome Sequencing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or ...

Report Code : A00391 | Category : Life Sciences

Urinary Tract Cancer Market: Global Opportunity Analysis and Industry Forecast, 2021––2030

The global urinary tract cancer market was valued at $1,704.5 million in 2020, and is estimated to reach $8,786.2 million by 2030, growing at a CAGR of 18.6% from 2021 to 2030.

Report Code : A00493 | Pages : 249 | Category : Life Sciences

Cancer Biomarkers Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The cancer biomarkers market was valued at $10,944.08 million in 2019, and is projected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027.Cancer biomarkers are traceable substances or molecules that indicate the existence of cancerous cells in the body.

Report Code : A01124 | Pages : 338 | Category : Life Sciences

Prostate Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

The global prostate cancer market is poised to grow at an exponential pace, primarily due to the mounting prevalence of prostate cancer, rapidly aging population and strong bolstering ...

Report Code : A01131 | Category : Life Sciences

Cancer Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.

Report Code : A01134 | Pages : 284 | Category : Life Sciences

Global cancer immunotherapies market by Technology : Global Opportunity Analysis and Industry Forecast, 2023-2032

Cancer Immunotherapies has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be defined as, the treatment that deploys the body’s immune system, by joining and boosting innate powers of the immune system to fight cancer.

Report Code : A01147 | Category : Life Sciences

Hormone Refractory Breast Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Breast cancer is one of the most common type of malignant cancers, which is prevalent in women above 40 years. As per World Health Organization (WHO) estimates, breast ...

Report Code : A01149 | Category : Life Sciences

Cancer Immunotherapy Market: Global Opportunity Analysis and Industry Forecast, 2021-2030

The global cancer immunotherapy market size was valued at $85,603.50 million in 2020, and is projected to reach $309,667.65 million by 2030, registering a CAGR of 14.1% from 2021 to 2030.

Report Code : A01913 | Pages : 207 | Category : Life Sciences

Cervical Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, ...

Report Code : A02242 | Category : Life Sciences

Gastrointestinal Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, ...

Report Code : A02248 | Category : Life Sciences

Cancer Gene Therapy Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

The global cancer gene therapy market was valued at $1.4 billion in 2020, and is projected to reach $11.4 billion by 2030, growing at a CAGR of 23.3% from 2021 to 2030.

Report Code : A02273 | Pages : 186 | Category : Life Sciences

Prostate Cancer Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.

Report Code : A02321 | Pages : 188 | Category : Life Sciences

Cancer Tumor Profiling Market:

Global Cancer/tumor Profiling Market was valued at $25,318 million in 2016, and is expected to reach $82,447 million by 2023, registering a CAGR of 18.4% from 2017 to ...

Report Code : A02384 | Pages : 190 | Category : Life Sciences

Bladder Cancer Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Bladder cancer is the rapid, uncontrolled growth of abnormal cells in the urinary bladder lining with epithelial cells. These cancerous cells may even spread through the lining into ...

Report Code : A02464 | Category : Life Sciences

Lung Cancer Therapeutic Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cancer is a chronic disease that involves the abnormal growth of cells inside the body, which further results in the formation of tumor. If untreated, the tumor grows, ...

Report Code : A03906 | Category : Life Sciences

Cancer IVD Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code : A04477 | Category : Life Sciences

Cancer Pain Market: Global Opportunity Analysis and Industry Forecast, 2021––2030

The global cancer pain market was valued at $6,197.8 million in 2020, and is estimated to reach $10,329.4 million by 2030, growing at a CAGR of 5.3% from 2021 to 2030.

Report Code : A04761 | Pages : 189 | Category : Life Sciences

Cancer Stem Cells Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

The global cancer stem cells market was valued at $1.1 billion in 2021 and is projected to reach $2.7 billion by 2031, growing at a CAGR of 10% from 2022 to 2031.

Report Code : A08105 | Pages : 200 | Category : Life Sciences

Cancer Cachexia Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is a result multiple factors, due to a complex interaction of tumor and host factors.

Report Code : A08106 | Category : Life Sciences